Gene · 6139
Papers2,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance. | Cell Rep Med | 2026 | 41564866 | PubTator, text mining | PubMed |
| Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy. | Nat Commun | 2026 | 41559042 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis of prognostic model and immune microenvironment in intrahepatic cholangiocarcinoma. | Transl Oncol | 2026 | 41558145 | PubTator, text mining | PubMed |
| Integrative multiomics dissection of LSM7 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma. | Sci Prog | 2026 | 41553301 | PubTator, text mining | PubMed |
| Otubain deubiquitinases: Multi-layered regulators of cell fate, development, and stress responses across kingdoms. | iScience | 2026 | 41550777 | PubTator, text mining | PubMed |
| Exploring the role of specialized pro-resolving mediators, fatty acid oxidation markers and transporters in Gestational Diabetes Mellitus (GDM) placentae. | Placenta | 2026 | 41475276 | PubTator, text mining | PubMed |
| Protectin D1 and maresin 1 attenuate airway hyperreactivity induced by IL-13 in human isolated small bronchi. | Br J Pharmacol | 2026 | 41401946 | PubTator, text mining | PubMed |
| Gene Regulation in Comorbid Migraine and Myogenic Temporomandibular Disorder Pain. | Genes (Basel) | 2025 | 41465107 | PubTator, text mining | PubMed |
| Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells. | Int J Mol Sci | 2025 | 41373892 | PubTator, text mining | PubMed |
| Protectin D1/GPR37 signaling enhances macrophage-dependent efferocytosis to attenuate experimental abdominal aortic aneurysm formation. | bioRxiv | 2025 | 41278733 | PubTator, text mining | PubMed |
| Transcriptomic insights into the anti-apoptotic effect of Tuina in rabbit model of intervertebral disc degeneration. | J Orthop Surg Res | 2025 | 41254757 | PubTator, text mining | PubMed |
| RPL17 regulates the progression of breast cancer accompanied by MAPK signaling activation. | Med Oncol | 2025 | 41222803 | PubTator, text mining | PubMed |
| The CYP1A1/ chimeric RNA RPL17-C18orf32 axis mediates Benzo[ghi]perylene induced-respiratory toxicity and DNA damage in vitro and in vivo. | Ecotoxicol Environ Saf | 2025 | 41218492 | PubTator, text mining | PubMed |
| The methyltransferase-like proteins as core regulators of nucleic acid modifications and post-translation modification of proteins in disease pathogenesis and therapeutic implications. | Biomark Res | 2025 | 41194259 | PubTator, text mining | PubMed |
| Immune therapies for alopecia areata: evidence and new perspectives. | Expert Rev Clin Immunol | 2025 | 41082367 | PubTator, text mining | PubMed |
| Comprehensive characterization of lysosome-dependent cell death reveals prognostic significance and immune landscape in colon adenocarcinoma. | Sci Rep | 2025 | 41006689 | PubTator, text mining | PubMed |
| Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections. | Sci Adv | 2025 | 41004596 | PubTator, text mining | PubMed |
| PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic Resistance. | Curr Treat Options Oncol | 2025 | 41003885 | PubTator, text mining | PubMed |
| Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K. | J Funct Biomater | 2025 | 41003423 | PubTator, text mining | PubMed |
| Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. | Cells | 2025 | 41002429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6139/papers?page=3